The use of cannabidiol (CBD) in pain reduction and opioid use after shoulder arthroscopy: A Double-Blind Randomized Control Study

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Shoulder Arthroscopy
  • Age: Between 18 years - 75 years
  • Gender: Male or Female
  • Other Inclusion Criteria:
    1. Subject undergoing an arthroscopic shoulder procedure (rotator cuff repair, decompression, labrum repair)
    2. Subject ages 18-75, willing and able to give written informed consent and comply with the requirements of this Clinical Investigation Plan
    3. Female subjects must be currently practicing effective forms of two types of birth control, which are defined as those, alone or in combination, that result in a low failure rate (less than 1% per year) when used consistently and correctly
    4. Male subjects must be using an effective form of contraception

You may not be eligible for this study if the following are true:

    1. Legally incompetent or mentally impaired
    2. Participatns considered a vulnerable subject: pregnant women or fetuses, children, cognitively impaired adults, prisoners
    3. History of cannabis abuse or dependence
    4. History of coagulation abnormalities and thromboembolic disease or current abnormal coagulation test values
    5. History of stroke or acute coronary syndromes within 3 months before surgery
    6. Abnormal coagulation profile
    7. Renal failure (serum creatinine > 250?µmol/L [2.83?mg/dL]) or liver cirrhosis
    8. History of hypersensitivity to Percocet
    9. Participants on a pre-operative opioid management for any reason
    10. Current or a history of major psychiatric illness, such as bipolar disorder
    11. Current or a history of major depression, psychosis, or substance abuse disorder
    12. Current or a history of suicidal ideation
    13. Breastfeeding females
    14. Has clinically significant illness, including cardiovascular disorders
    15. With clinically significant lab abnormalities
    16. Has major neurological disorders, such as dementia, Parkinson’s disease, cognitive impairment, epilepsy, history of traumatic brain/head injury, or seizures
    17. Has moderate (Child-Pugh B) and severe hepatic impairment (Child-Pugh C).

If you are registered as a volunteer, please log in to contact the study team/express interest in this study.